ARCHIVES

Economic Analyses Of New Therapies Useful In Phase III Studies, Trialists Say

This article is from The Cancer Letter archive.

Vol. 35 No. 29 | July 24, 2009

Download PDF Visit The Full Archive

Related Articles

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014

Columnist, Kushner, Four Others Names To NCAB

May 9, 1980

GAO Criticizes Eppley, NCI For ‘Deficiencies’ In Review, Monitoring, Management of Contract

February 24, 1978

Attempt To Push NCI To Establish Diagnostic Coordinating Group Fails

July 5, 1974

DCPC Developing Hispanic Cancer Control Intervention Program Concept

August 12, 1988

Also in This 8-page Issue: In Overhaul of Ethics Rules, NIH Bans Employees From Consulting for and Owning Stock in Biomedical Companies.

February 4, 2005